Quick infos Trade prices Volume: Market Cap: 135.88M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: March 13, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast May 15, 2023 March 27, 2023 - / -0.629- / -November 10, 2022 -0.84 / -0.78751.13M / 120KAugust 11, 2022 -0.88 / -0.585- / 2.08MMay 10, 2022 -0.57 / -0.67432.55M / 2.57MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jul 15, 2022 6.150 6.130 6.150
6.050
332.66K 0.16% Jul 14, 2022 6.140 6.180 6.230
6.110
459.41K -0.49% Jul 13, 2022 6.170 6.200 6.250
6.140
531.12K -0.64% Jul 12, 2022 6.210 6.170 6.240
6.170
302.81K 0.16% Jul 11, 2022 6.200 6.220 6.250
6.180
303.88K -0.64% Jul 8, 2022 6.240 6.260 6.320
6.170
380.70K -0.16% Jul 7, 2022 6.250 6.240 6.325
6.210
331.64K -0.16% Jul 6, 2022 6.260 6.220 6.280
6.140
339.32K -0.16% Jul 5, 2022 6.270 6.270 6.300
6.130
571.72K -0.4% Jul 1, 2022 6.295 6.260 6.340
6.240
272.19K 0.56% view more
News
F-star Therapeutics gains after extending sale end date to Sino-Biopharma to Dec. 19 seekingalpha.com Nov 21, 2022 11:44 pm MMAT, EAF and ELP among pre market gainers seekingalpha.com Nov 21, 2022 9:53 pm F-star Therapeutics sale to Sino-Biopharma withdrawn, refiled with CFIUS seekingalpha.com Nov 1, 2022 9:29 pm
F-star Therapeutics Inc to Host Earnings Call finance.yahoo.com Jul 18, 2022 7:15 am
How Much Of F-star Therapeutics, Inc. (NASDAQ:FSTX) Do Institutions Own? finance.yahoo.com Jun 24, 2022 8:06 am
F-star Therapeutics, Inc. (NASDAQ:FSTX) Just Reported And Analysts Have Been Cutting Their Estimates finance.yahoo.com May 14, 2022 8:44 am F-star Therapeutics falls for a second day as CFIUS deadline set to expire seekingalpha.com Nov 1, 2022 12:42 am F-star Therapeutics pares drop amid concern about CFIUS approval for Sino-Biopharma (update) seekingalpha.com Oct 28, 2022 10:20 pm Amazon.com, Pinduoduo, JD.com among premarket losers' pack seekingalpha.com Oct 28, 2022 8:24 pm F-star Therapeutics falls on extended CFIUS review for Sino-Biopharma sale seekingalpha.com Sep 16, 2022 5:07 am F-star Therapeutics GAAP EPS of -$0.88 seekingalpha.com Aug 11, 2022 9:03 pm F-star enters license deal with Takeda for a cancer immune therapy antibody seekingalpha.com Jul 20, 2022 9:55 pm F-star Therapeutics stock soars 71% as Sino Biopharma set to acquire it for $161M seekingalpha.com Jun 23, 2022 8:01 pm F-star Therapeutics GAAP EPS of -$0.57 beats by $0.11, revenue of $2.55M beats by $0.99M seekingalpha.com May 10, 2022 8:02 pm
F-star Therapeutics to Announce First Quarter Results and Host Conference Call on Tuesday, May 10th, 2022 finance.yahoo.com May 2, 2022 9:00 am
Strong week for F-star Therapeutics (NASDAQ:FSTX) shareholders doesn't alleviate pain of one-year loss finance.yahoo.com Mar 21, 2022 4:12 pm F-star Therapeutics GAAP EPS of -$1.88 beats by $0.37, revenue of $21.17M beats by $5.85M seekingalpha.com Mar 14, 2022 8:09 pm
F-star Therapeutics to Present at theĀ 32nd Annual Oppenheimer Healthcare Conference finance.yahoo.com Mar 10, 2022 8:00 am
F-star Therapeutics Appoints James Sandy as Chief Development Officer finance.yahoo.com Mar 1, 2022 8:00 am F-star Therapeutics gets US patent for antibody FS118 seekingalpha.com Jan 20, 2022 11:48 pm This company doesn't provide a dividend.
Talk about Spring Bank below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.